The Lung Research Center, LLC

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis8 trials
• Bronchiectasis1 trial

Phase

• Phase 35 trials
• Phase 24 trials

Status

• Active, not recruiting3 trials
• Completed3 trials
• Recruiting2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Boehringer Ingelheim4 trials
• United Therapeutics2 trials
• Bridge Biotherapeutics, Inc.1 trial
• Daewoong Pharmaceutical Co. LTD.1 trial
• Rein Therapeutics1 trial

Running trials

• Recruiting

  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06968845· Phase 2· Rein Therapeutics· Source

  Contact: Anna Shipp

• Active, not recruiting

  A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

  NCT07036523· Phase 2· Boehringer Ingelheim· Source

• Active, not recruiting

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· Phase 3· United Therapeutics· Source

  Contact: Anna Shipp

• Enrolling by invitation

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· Phase 3· United Therapeutics· Source

• Active, not recruiting

  Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

  NCT05389215· Phase 2· Daewoong Pharmaceutical Co. LTD.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Idiopathic pulmonary fibrosis3 recruiting

Closed trials

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Completed

  To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

  NCT05483907· Phase 2· Bridge Biotherapeutics, Inc.· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Boehringer Ingelheim· Source